BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:afb6c80c-bb81-430b-8a51-c341114497e1
DTSTAMP:20251027T221301Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:43dbddea-7a04-44f7-ba76-4d89e14626d7
DTSTAMP:20251027T221301Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:cd4374d7-81b0-4b05-a697-82d5ee9dc04f
DTSTAMP:20251027T221301Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:83a41c1e-fc98-42d7-96a9-e257d33bd71f
DTSTAMP:20251027T221301Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:7945e54e-7b2e-4053-9492-609847c91aa5
DTSTAMP:20251027T221301Z
DTSTART:20251016T090000Z
DTEND:20251016T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Self paced
END:VEVENT
BEGIN:VEVENT
UID:f199f890-bc22-458a-9bfc-e6ac09105e68
DTSTAMP:20251027T221301Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:c50591e8-0310-4f34-b233-162f03033b4f
DTSTAMP:20251027T221301Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:0edae5ed-2879-4c9f-a391-094d82520a22
DTSTAMP:20251027T221301Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:2b70db63-f0e6-4f70-8e1d-692614cbcb00
DTSTAMP:20251027T221301Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:4006c5d6-ed79-4d62-bab5-cf2e3a8241a2
DTSTAMP:20251027T221301Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:91fad63d-dc15-48a2-833e-5f6dacf713cf
DTSTAMP:20251027T221301Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:b8098e95-a661-42a0-93c1-8a47048a42f1
DTSTAMP:20251027T221301Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:22551010-bbf3-4115-aece-1c17f99b3ee2
DTSTAMP:20251027T221301Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:0d561291-4c5d-4904-b7c1-0f1c05b9d7b9
DTSTAMP:20251027T221301Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:cbe0fec5-be5b-4a70-a858-0a35526b67e7
DTSTAMP:20251027T221301Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:ddafa6de-9565-443e-a701-d11e8ba12733
DTSTAMP:20251027T221301Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:8a6f374a-a5b3-4f4c-b41e-7aabba774d15
DTSTAMP:20251027T221301Z
DTSTART:20251205T150000Z
DTEND:20251205T160000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:e7d3ec90-2d95-4f16-9144-7f8e48cd29ff
DTSTAMP:20251027T221301Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:902efc5d-9589-48b9-921f-114ce72d73dd
DTSTAMP:20251027T221301Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:21efc699-c5eb-4d14-a18e-eac7192d7a13
DTSTAMP:20251027T221301Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:TBC
END:VEVENT
END:VCALENDAR
